C
TransMedics Group, Inc.
TMDX
$67.08
-$0.57-0.84%
C
Hold
2/28/2025Upgraded
TransMedics Group, Inc. (TMDX) was upgraded to C- from D+ on 2/28/2025 due to a large increase in the growth index, efficiency index and valuation index. Operating cash flow increased 186.76% from $6.86M to $19.66M, EBIT increased 120.34% from $3.92M to $8.64M, and earnings per share increased from $0.12 to $0.2.
TransMedics Group, Inc. (TMDX) was upgraded to C- from D+ on 2/28/2025 due to a large increase in the growth index, efficiency index and valuation index. Operating cash flow increased 186.76% from $6.86M to $19.66M, EBIT increased 120.34% from $3.92M to $8.64M, and earnings per share increased from $0.12 to $0.2.
D
Sell
10/28/2024Downgrade
TransMedics Group, Inc. (TMDX) was downgraded to D+ from C- on 10/28/2024 due to a substantial decline in the total return index.
TransMedics Group, Inc. (TMDX) was downgraded to D+ from C- on 10/28/2024 due to a substantial decline in the total return index.
C
Hold
8/2/2024Upgraded
TransMedics Group, Inc. (TMDX) was upgraded to C- from D- on 8/2/2024 due to a large increase in the efficiency index and growth index. Operating cash flow increased 848.7% from -$3.44M to $25.72M, total revenue increased 18.02% from $96.85M to $114.31M, and total capital increased 4.54% from $675.69M to $706.39M.
TransMedics Group, Inc. (TMDX) was upgraded to C- from D- on 8/2/2024 due to a large increase in the efficiency index and growth index. Operating cash flow increased 848.7% from -$3.44M to $25.72M, total revenue increased 18.02% from $96.85M to $114.31M, and total capital increased 4.54% from $675.69M to $706.39M.
D
Sell
3/14/2023Downgrade
TransMedics Group, Inc. (TMDX) was downgraded to D- from D on 3/14/2023 due to a decline in the solvency index and valuation index. The quick ratio declined from 10.95 to 9.67.
TransMedics Group, Inc. (TMDX) was downgraded to D- from D on 3/14/2023 due to a decline in the solvency index and valuation index. The quick ratio declined from 10.95 to 9.67.
D
Sell
2/23/2023Upgraded
TransMedics Group, Inc. (TMDX) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index.
TransMedics Group, Inc. (TMDX) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index.
D
Sell
2/8/2023Downgrade
TransMedics Group, Inc. (TMDX) was downgraded to D- from D on 2/8/2023 due to a decline in the growth index and valuation index. Operating cash flow declined 57.05% from -$9.09M to -$14.28M.
TransMedics Group, Inc. (TMDX) was downgraded to D- from D on 2/8/2023 due to a decline in the growth index and valuation index. Operating cash flow declined 57.05% from -$9.09M to -$14.28M.
D
Sell
5/31/2022Upgraded
TransMedics Group, Inc. (TMDX) was upgraded to D from D- on 5/31/2022 due to an increase in the total return index and volatility index.
TransMedics Group, Inc. (TMDX) was upgraded to D from D- on 5/31/2022 due to an increase in the total return index and volatility index.
D
Sell
5/13/2022Downgrade
TransMedics Group, Inc. (TMDX) was downgraded to D- from D on 5/13/2022 due to a decline in the solvency index, volatility index and valuation index. Debt to equity increased from 0.52 to 0.61, and the quick ratio declined from 4.23 to 4.13.
TransMedics Group, Inc. (TMDX) was downgraded to D- from D on 5/13/2022 due to a decline in the solvency index, volatility index and valuation index. Debt to equity increased from 0.52 to 0.61, and the quick ratio declined from 4.23 to 4.13.
D
Sell
5/5/2022Upgraded
TransMedics Group, Inc. (TMDX) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index.
TransMedics Group, Inc. (TMDX) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index.
D
Sell
4/20/2022Downgrade
TransMedics Group, Inc. (TMDX) was downgraded to D- from D on 4/20/2022 due to a large decline in the total return index, solvency index and volatility index. The quick ratio declined from 6.73 to 4.23, and debt to equity increased from 0.45 to 0.52.
TransMedics Group, Inc. (TMDX) was downgraded to D- from D on 4/20/2022 due to a large decline in the total return index, solvency index and volatility index. The quick ratio declined from 6.73 to 4.23, and debt to equity increased from 0.45 to 0.52.
D
Sell
11/10/2021Upgraded
TransMedics Group, Inc. (TMDX) was upgraded to D from D- on 11/10/2021 due to an increase in the valuation index and total return index.
TransMedics Group, Inc. (TMDX) was upgraded to D from D- on 11/10/2021 due to an increase in the valuation index and total return index.
D
Sell
11/8/2021Downgrade
TransMedics Group, Inc. (TMDX) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index.
TransMedics Group, Inc. (TMDX) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index.
D
Sell
7/8/2020Upgraded
TransMedics Group, Inc. (TMDX) was upgraded to D from D- on 7/8/2020 due to an increase in the total return index and volatility index.
TransMedics Group, Inc. (TMDX) was upgraded to D from D- on 7/8/2020 due to an increase in the total return index and volatility index.
D
Sell
6/23/2020Downgrade
TransMedics Group, Inc. (TMDX) was downgraded to D- from D on 6/23/2020 due to a decline in the volatility index and valuation index.
TransMedics Group, Inc. (TMDX) was downgraded to D- from D on 6/23/2020 due to a decline in the volatility index and valuation index.
D
Sell
6/5/2020Upgraded
TransMedics Group, Inc. (TMDX) was upgraded to D from D- on 06/05/2020.
TransMedics Group, Inc. (TMDX) was upgraded to D from D- on 06/05/2020.
D
Sell
2/4/2020Upgraded
TransMedics Group, Inc. (TMDX) was upgraded to D- from E on 2/4/2020 due to an increase in the growth index. Operating cash flow increased 53.97% from -$12.16M to -$5.6M, earnings per share increased from -$0.7001 to -$0.3918, and total revenue increased 27.16% from $5.67M to $7.21M.
TransMedics Group, Inc. (TMDX) was upgraded to D- from E on 2/4/2020 due to an increase in the growth index. Operating cash flow increased 53.97% from -$12.16M to -$5.6M, earnings per share increased from -$0.7001 to -$0.3918, and total revenue increased 27.16% from $5.67M to $7.21M.
E
Sell
11/5/2019Upgraded
TransMedics Group, Inc. (TMDX) was upgraded to E from E- on 11/5/2019 due to a large increase in the solvency index, growth index and efficiency index. The quick ratio increased from 1.07 to 6.72, total capital increased 379.94% from $21.89M to $105.06M, and earnings per share increased from -$4.8613 to -$0.7001.
TransMedics Group, Inc. (TMDX) was upgraded to E from E- on 11/5/2019 due to a large increase in the solvency index, growth index and efficiency index. The quick ratio increased from 1.07 to 6.72, total capital increased 379.94% from $21.89M to $105.06M, and earnings per share increased from -$4.8613 to -$0.7001.
E
Sell
8/5/2019Downgrade
TransMedics Group, Inc. (TMDX) was downgraded to E- from E on 8/5/2019 due to a large decline in the volatility index.
TransMedics Group, Inc. (TMDX) was downgraded to E- from E on 8/5/2019 due to a large decline in the volatility index.
E
Sell
7/26/2019None
TransMedics Group, Inc. (TMDX) was downgraded to E from U on 07/26/2019.
TransMedics Group, Inc. (TMDX) was downgraded to E from U on 07/26/2019.
NASDAQ
03/12/2025 4:00PM Eastern
Quotes delayed
